Breaking News Instant updates and real-time market news.

GIS

General Mills

$44.99

-2.78 (-5.82%)

10:00
09/18/18
09/18
10:00
09/18/18
10:00

Technical Take: General Mills falls sharply after earnings

The stock was last down over 8% to $43.93. At that price the next significant level of support is at the 52-week low at $41.01. Resistance is at $45.12.

  • 18

    Sep

  • 28

    Oct

GIS General Mills
$44.99

-2.78 (-5.82%)

09/17/18
MSCO
09/17/18
INITIATION
Target $47
MSCO
Equal Weight
Mondelez assumed with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Dara Mohsenian assumed coverage of Mondelez (MDLZ) with an Equal Weight rating and $47 price target, calling it the best positioned among the large cap food peers on which he began coverage. However, Mohsenian assumed the U.S. large-cap packaged food industry with an In-Line rating, stating that he is cautious fundamentally given his skepticism over packaged food sector topline growth and margin expansion potential. Mohsenian also assumed coverage of General Mills (GIS) and Kellogg (K) with Equal Weight ratings and assumed Kraft Heinz (KHC) with an Underweight rating.
09/17/18
RBCM
09/17/18
NO CHANGE
Target $52
RBCM
Sector Perform
General Mills price target raised to $52 at RBC Capital on more stable trends
RBC Capital analyst David Palmer nudged his price target on General Mills to $52 from $50 and kept his Sector Perform rating, saying that while the company's sales trends have not accelerated as much as its peers, they have been more stable and relied less on promotional activity. The analyst notes that the company faces a more challenging cereal comparison ahead, but also offers investors a "compelling free cash flow" and has some further sources of upside such as distribution gains for Blue Buffalo along with the recent wins like gains in yogurt category. Palmer also nudged his FY19 EPS view on General Mills to $3.06 from $3.04.
09/17/18
09/17/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Reliance Steel (RS) initiated with a Neutral at Citi. 2. Bausch Health (BHC) assumed with an Overweight at Barclays. 3. Stanley Black & Decker (SWK) initiated with an Outperform at Credit Suisse. 4. Aramark (ARMK) initiated with an Outperform at Bernstein. 5. Kraft Heinz (KHC) was assumed with an Underweight at Morgan Stanley, while Mondelez (MDLZ), General Mills (GIS), and Kellogg (K) were assumed with an Equal Weight. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/17/18
09/17/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. LULULEMON UPGRADED TO OUTPERFORM: Wells Fargo analyst Ike Boruchow upgraded Lululemon (LULU) to Outperform from Market Perform, stating that while the brand's current strength is "evident to essentially everyone," his recent meetings with management lead him to believe that its "industry leading" momentum is likely sustainable through the second half of this year and well into 2019. While admitting to being "late to the party," Boruchow said he sees meaningful outperformance and upward revisions being ahead for the athletic apparel company. He raised his price target on Lululemon shares to $200 from $144. In late morning trading, Lululemon shares are higher by 2.3%. NOMURA UPGRADES BROADCOM TO BUY: Nomura Instinet analyst Romit Shah upgraded Broadcom (AVGO) to Buy from Neutral and raised his price target for the shares to $300 from $225. The analyst says the "so many positive takeaways from earnings" have forced him to take a more constructive stance on the shares. GOLDMAN SWAPS CONVICTION BUY ON MASTERCARD, VISA: Goldman Sachs analyst James Schneider added MasterCard (MA) to his firm's Conviction List while maintaining a Buy rating on the shares. The analyst also upped his price target for the stock to $260 from $230. Goldman Sachs analyst James Schneider removed Visa (V) from his firm's Conviction List but maintains a Buy rating on the shares with an unchanged price target of $160. The analyst, who continues to see upside to Street estimates, cites the recent share outperformance for the removal. MORGAN STANLEY INITIATES CONSUMER STAPLES: Morgan Stanley analyst Dara Mohsenian assumed Kraft Heinz (KHC) with an Underweight and $52 price target, as he believes it topline growth will likely trail food peers. In late morning trading, Kraft Heinz shares were down almost 2%. The analyst also assumed coverage of Mondelez (MDLZ), General Mills (GIS), and Kellogg (K) with Equal Weight ratings. KEYBANC SEES CANNABIS AS DRIVER FOR SHOPIFY: KeyBanc analyst Monika Garb said she is a buyer of Shopify (SHOP), as the company has "ample" growth opportunities ahead, and she sees potential upside to her above-consensus estimates. She expects that recreational sales of cannabis in Canada could be a GMV and revenue driver and further benefit Shopify's business momentum. Garb maintained an Overweight rating and $182 price target on the shares.

TODAY'S FREE FLY STORIES

BXP

Boston Properties

$114.70

0.3 (0.26%)

05:25
10/15/18
10/15
05:25
10/15/18
05:25
Upgrade
Boston Properties rating change  »

Boston Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 07

    Nov

SHLD

Sears

$0.40

0.05 (14.28%)

05:25
10/15/18
10/15
05:25
10/15/18
05:25
Hot Stocks
Sears, Kmart stores will remain open during holiday season »

Sears Chairman Edward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.40

0.05 (14.28%)

05:23
10/15/18
10/15
05:23
10/15/18
05:23
Hot Stocks
Sears adds William Transier as new independent director to board »

William Transier, CEO of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZO

Carrizo Oil & Gas

$22.09

0.33 (1.52%)

05:22
10/15/18
10/15
05:22
10/15/18
05:22
Upgrade
Carrizo Oil & Gas rating change  »

Carrizo Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.40

0.05 (14.28%)

05:22
10/15/18
10/15
05:22
10/15/18
05:22
Hot Stocks
Sears appoints Mohsin Meghji as Chief Restructuring Officer »

Mohsin Meghji, Managing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$12.39

0.415 (3.47%)

05:21
10/15/18
10/15
05:21
10/15/18
05:21
Upgrade
Oasis Petroleum rating change  »

Oasis Petroleum upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.40

0.05 (14.28%)

05:20
10/15/18
10/15
05:20
10/15/18
05:20
Hot Stocks
Sears CEO Edward Lampert steps down as CEO, board creates 'Office of the CEO' »

Edward Lampert has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.40

0.05 (14.28%)

05:18
10/15/18
10/15
05:18
10/15/18
05:18
Hot Stocks
Sears files voluntary petitions for relief under Chapter 11 Bankruptcy »

Sears Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

, AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

05:18
10/15/18
10/15
05:18
10/15/18
05:18
Recommendations
Adamas Pharmaceuticals, Agios Pharmaceuticals, Alnylam, Alexion, Bluebird Bio, BioMarin, CymaBay, Crispr Therapeutics, Global Blood Therapeutics, Horizon Pharma, Jazz Pharmaceuticals, Ocular Therapeutix, Rigel Pharmaceuticals, Xencor analyst commentary  »

Piper lists names to own…

ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

ALNY

Alnylam

$82.00

2.51 (3.16%)

ALXN

Alexion

$121.91

2.62 (2.20%)

BLUE

Bluebird Bio

$125.92

-0.81 (-0.64%)

BMRN

BioMarin

$99.60

2.28 (2.34%)

CBAY

CymaBay

$10.19

0.19 (1.90%)

CRSP

Crispr Therapeutics

$37.74

0.85 (2.30%)

GBT

Global Blood Therapeutics

$33.01

1.46 (4.63%)

HZNP

Horizon Pharma

$18.27

0.23 (1.27%)

JAZZ

Jazz Pharmaceuticals

$158.82

3.42 (2.20%)

OCUL

Ocular Therapeutix

$6.09

-0.02 (-0.33%)

RIGL

Rigel Pharmaceuticals

$3.10

0.005 (0.16%)

XNCR

Xencor

$35.08

1.04 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 07

    Nov

  • 27

    Nov

  • 01

    Dec

  • 20

    Dec

  • 28

    Dec

  • 18

    Feb

SHLD

Sears

$0.40

0.05 (14.28%)

05:16
10/15/18
10/15
05:16
10/15/18
05:16
Hot Stocks
Breaking Hot Stocks news story on Sears »

Sears CEO Edward Lampert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$0.40

0.05 (14.28%)

05:14
10/15/18
10/15
05:14
10/15/18
05:14
Hot Stocks
Breaking Hot Stocks news story on Sears »

Sears files voluntary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$61.57

1.75 (2.93%)

05:12
10/15/18
10/15
05:12
10/15/18
05:12
Recommendations
Alaska Air analyst commentary  »

Alaska Air deserves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 27

    Nov

CTMX

CytomX Therapeutics

$15.76

0.44 (2.87%)

05:09
10/15/18
10/15
05:09
10/15/18
05:09
Initiation
CytomX Therapeutics initiated  »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPR

Tapestry

$43.81

1.13 (2.65%)

05:08
10/15/18
10/15
05:08
10/15/18
05:08
Downgrade
Tapestry rating change  »

Tapestry downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EB

Eventbrite

$28.12

0.23 (0.82%)

05:04
10/15/18
10/15
05:04
10/15/18
05:04
Initiation
Eventbrite initiated  »

Eventbrite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$32.66

0.31 (0.96%)

05:02
10/15/18
10/15
05:02
10/15/18
05:02
Initiation
Elanco initiated  »

Elanco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ZTS

Zoetis

$88.90

1.84 (2.11%)

04:59
10/15/18
10/15
04:59
10/15/18
04:59
Upgrade
Zoetis rating change  »

Zoetis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

KSU

Kansas City Southern

$102.56

-0.41 (-0.40%)

04:57
10/15/18
10/15
04:57
10/15/18
04:57
Upgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
L3 Technologies and Harris to hold a joint conference call »

The companies hold a…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

IHRT

iHeartMedia

$0.00

(0.00%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen TMT analyst Vitanza to hold an analyst/industry conference call »

Technology, Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

OKE

Oneok

$64.99

-0.24 (-0.37%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Oneok management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 31

    Oct

TEUM

Pareteum

$2.55

0.02 (0.79%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Pareteum management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 07

    Nov

  • 15

    Nov

FDX

FedEx

$220.97

3.54 (1.63%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
FedEx management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

REFR

Research Frontiers

$1.73

0.03 (1.76%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Research Frontiers management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.